KAINOS LaboratoriesTSE:4556 39 Net Margin % is 5.27% as of Mar. 2026, which is 43% below its 10-year median of 9.23. GuruFocus rates TSE:4556 with a GF Score™ of 39/100 and a GF Value™ of 円1,281.99 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 814 Medical Devices & Instruments companies, KAINOS Laboratories ranks better than 67.94% on this metric.
The historical rank and industry rank for KAINOS Laboratories's Net Margin % or its related term are showing as below:
TSE:4556'
s Net Margin % Range Over the Past 10 Years
Min: 6.34 Med: 9.23 Max: 12.62
Current: 8.2
TSE:4556's Net Margin % is ranked better than 67.94% of 814
companies
in the Medical Devices & Instruments industry
Industry Median: 2.06
vs TSE:4556: 8.20
KAINOS Laboratories (TSE:4556) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
KAINOS Laboratories Net Margin % Related Terms
KAINOS Laboratories Net Margin % Historical Data
* Premium members only.
The historical data trend for KAINOS Laboratories's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4556 vs ISRG, BDX, MDLN: Net Margin % Comparison
For the Medical Instruments & Supplies subindustry, KAINOS Laboratories's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KAINOS Laboratories Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KAINOS Laboratories's Net Margin % distribution charts can be found below:
* The bar in red indicates where KAINOS Laboratories's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KAINOS Laboratories (TSE:4556) has a Net Margin % of 5.27% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on KAINOS Laboratories and its competitors. This is 43% below median its historical median of 9.23. Over the past decade, KAINOS Laboratories' Net Margin % has ranged from 6.34 to 12.62. According to the industry distribution chart, KAINOS Laboratories ranks #261 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 32.1%.
Is KAINOS Laboratories' Net Margin % too high?
KAINOS Laboratories' current Net Margin % of 5.27% is 43% below median its 10-year median of 9.23. Over the past 10 years, this metric has ranged from a low of 6.34 to a high of 12.62. The Medical Devices & Instruments industry median Net Margin % is 2.06. KAINOS Laboratories' value of 5.27% is 155.8% above this industry median. Based on the distribution chart, KAINOS Laboratories ranks #261 out of 814 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, KAINOS Laboratories has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KAINOS Laboratories' Net Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, KAINOS Laboratories ranks #261 out of 814 companies for Net Margin %. This puts KAINOS Laboratories in the upper half of its industry. The industry median Net Margin % is 2.06. KAINOS Laboratories' value of 5.27% is 155.8% above this benchmark. Historically, KAINOS Laboratories' own Net Margin % has ranged from 6.34 to 12.62 over the past decade. While the company's 10-year median is 9.23 vs. the industry median of 2.06, KAINOS Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.06, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KAINOS Laboratories's current Net Margin % of 5.27% is 155.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on KAINOS Laboratories and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KAINOS Laboratories's current Net Margin % is 5.27%, which is 43% below median its own 10-year median of 9.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KAINOS Laboratories stock overvalued right now?
Based on GuruFocus' analysis, KAINOS Laboratories (TSE:4556) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,281.99, compared to a current price of 円2,268.00 — trading 76.9% above its estimated fair value. The current Net Margin % is 5.27%, which is 43% below median its 10-year median of 9.23 and 155.8% above the Medical Devices & Instruments industry median of 2.06. KAINOS Laboratories' overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For KAINOS Laboratories (TSE:4556), the current Net Margin % is 5.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KAINOS Laboratories (TSE:4556) Overvalued in 2026?
Based on GuruFocus' analysis, KAINOS Laboratories stock appears to be overvalued.
The current stock price of 円2,268.00 is trading 76.9% above its estimated GF Value™ of 円1,281.99.
GuruFocus considers KAINOS Laboratories to be Significantly Overvalued.
Key valuation signals for TSE:4556:
Net Margin %: 5.27% (43% below median its 10-year median of 9.23)
GF Value™: 円1,281.99 vs. price of 円2,268.00 (76.9% above fair value)
Industry Position: 155.8% above the Medical Devices & Instruments median (#261 of 814)
No single metric tells the full story. See the TSE:4556 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KAINOS Laboratories Inc is focused on the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sells, and exports/imports physicochemical measuring equipment for medical use.
39GF Score
Get the complete analysis for TSE:4556
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4556 has been successfully added to your 
